• Vincent Medical posted 1H2026 revenue up 7.1% to HK$481.6 million; profit attributable to owners fell 15.7% to HK$43.5 million.
• Basic earnings per share slipped to HK6.71 cents; gross profit margin narrowed 1.1 percentage points to 34.3%.
• Imaging disposable products revenue rose 7.2% to HK$261.6 million; respiratory products edged down 1.9% to HK$124 million.
• Interim dividend cut to HK2 cents a share; record date Sept. 14, payment around Sept. 30.
• New Kaiping R&D and production facility remained on track for trial operations by end-2026, with phased ramp-up from 2027 onwards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vincent Medical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12297615), on August 25, 2026, and is solely responsible for the information contained therein.